Asia Pacific Anaphylaxis Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Medication Type (Epinephrine, Antihistamines, Steroids, Beta-Agonist, and Others), Route of Administration (Oral, Parenteral, and Others), Allergy Type (Food Allergy, Medications, Insect Stings, and Others) and Distribution Channel (Hospital Pharmacies, Retail Sales, and Others)
Market Introduction
Anaphylaxis is an allergic reaction that can further lead to a fatal condition known as anaphylactic shock. Anaphylaxis occurs when the patient's body reacts to a foreign substance and produces a high amount of histamine that triggers an inflammatory response. It is a severe, life threatening allergic reaction marked by indications such as swallowing and breathing difficulties, skin itching, and lowering blood pressure.
Thus, the rising incidence of anaphylaxis is expected to create a significant demand for anaphylaxis treatment in the coming years, which is further anticipated to drive the anaphylaxis treatment market.
Certainly, COVID-19 increases the risk of aggravating asthma and allergic diseases, but the government and private agencies are guiding for the treatments. According to guidelines of the Korean Academy of Asthma, Allergy and Clinical Immunology, and the Korean Academy of Pediatric Allergy and Respiratory Disease, detailed monitoring and optimal treatment with AIT, ICS, and biologics need to be continued in all patients who have asthma and allergic diseases. This can be achieved in a safe condition using optimal protective measures. Patients at high risk (older age and comorbid conditions) should be monitored more strictly. All the allergy/immunology specialists who strive to stay up for optimal health protection by focusing on patient management during the COVID-19 pandemic are necessary. As APAC passes through these challenging times of the COVID-19 pandemic, The Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) as an allergy/immunology community via its COVID-19 Task Force is carefully monitoring and updating Food and Drug Administration/Centers for Disease Control and Prevention/ WHO and other crucial scientific information on COVID-19 on its website COVID-19 resource section. Thus, the rising need for allergy treatment is likely to boost the market.
Get more information on this report :
Market Overview and Dynamics
The Anaphylaxis treatment market in Asia Pacific is expected to grow from US$ 350.7 million in 2021 to US$ 664.0 million by 2028; it is estimated to grow at a CAGR of 9.6% from 2021 to 2028. Anaphylaxis is a severe, life‑threatening allergic reaction caused by vulnerability to allergens (foods, insect stings, or medicines) identified as a non-self by a human body. Typical indications of this condition include swallowing and breathing difficulties, skin redness and itching, accelerated heart rate, wheezing, rapid breathing rate, and lowering blood pressure. The incidence of anaphylaxis is increasing around the world. Therefore, the rising incidence of allergies is leading to surge in anaphylaxis cases. Due to the growing prevalence of allergies, the economic burden on healthcare systems in many countries is increasing. Thus, the burgeoning incidence of anaphylaxis is driving the growth of the market.
Key Market Segments
In terms of medication type, the epinephrine segment accounted for the largest share of the Asia Pacific anaphylaxis treatment market in 2020. In terms of route of administration, the parenteral segment accounted for the largest share of the Asia Pacific anaphylaxis treatment market in 2020. In terms of allergy type, the food allergy segment accounted for the largest share of the Asia Pacific anaphylaxis treatment market in 2020. In terms of distribution channel, the retail pharmacies segment held a larger market share of the anaphylaxis treatment market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the anaphylaxis treatment market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Amneal Pharmaceuticals Inc., Mylan N.V., Abbott, Pfizer Inc., Glaxosmithkline Plc., Merck and Co., Inc., Teva Pharmaceutical Industries Ltd., and ALK-ABELLó.
Reasons to buy report
- To understand the Asia Pacific anaphylaxis treatment market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific anaphylaxis treatment market
- Efficiently plan M&A and partnership deals in Asia Pacific Anaphylaxis treatment market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific Anaphylaxis treatment market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Asia Pacific region.
ASIA PACIFIC ANAPHYLAXIS TREATMENT MARKET SEGMENTATION
By Medication Type
- Epinephrine
- Antihistamines
- Steroids
- Beta-Agonist
- Others
By Route of Administration
- Parenteral
- Oral
- Others
By Allergy Type
- Food Allergy
- Medications
- Insect Stings
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
By Country
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
Companies Mentioned
- Amneal Pharmaceuticals Inc.
- Mylan N.V.
- Abbott
- Pfizer Inc.
- Glaxosmithkline Plc.,
- Merck And Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- ALK-ABELLó
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Anaphylaxis Treatment Market – By Medication Type
1.3.2 Anaphylaxis Treatment Market – By Route of Administration
1.3.3 Anaphylaxis Treatment Market – By Allergy Type
1.3.4 Anaphylaxis Treatment Market – By Distribution Channel
1.3.5 Asia Pacific Anaphylaxis Treatment Market – By Country
2. Asia Pacific Anaphylaxis Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Anaphylaxis Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Anaphylaxis Treatment Market- Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Anaphylaxis Treatment Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Anaphylaxis
5.1.2 Recent Approvals for Epinephrine
5.2 Market Restraints
5.2.1 Poor Access to Epinephrine Auto-Injectors in Low-Income Countries
5.3 Market Opportunities
5.3.1 Rise in Cases of Allergies Post Administration of COVID-19 Vaccines
5.4 Future Trends
5.4.1 Novel Drug Delivery Systems
5.5 Impact Analysis
6. Anaphylaxis Treatment Market – Asia Pacific Analysis
6.1 Asia Pacific Anaphylaxis Treatment Market Revenue Forecasts and Analysis
7. Asia Pacific Anaphylaxis Treatment Market Analysis and Forecasts To 2028 – By Medication Type
7.1 Overview
7.2 Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)
7.3 Epinephrine
7.3.1 Overview
7.3.2 Epinephrine: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Antihistamines
7.4.1 Overview
7.4.2 Antihistamines: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Steroids
7.5.1 Overview
7.5.2 Steroids: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Beta-Agonist
7.6.1 Overview
7.6.2 Beta-Agonist: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8. Anaphylaxis Treatment Market Analysis – By Route of Administration
8.1 Overview
8.2 Anaphylaxis Treatment Market Revenue Share, by Route of Administration (2020 and 2028)
8.3 Oral
8.3.1 Overview
8.3.2 Oral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Parenteral
8.4.1 Overview
8.4.2 Parenteral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Anaphylaxis Treatment Market Analysis and Forecasts To 2028 – By Allergy Type
9.1 Overview
9.2 Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028, (%)
9.3 Food Allergy
9.3.1 Overview
9.3.2 Food Allergy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Medications
9.4.1 Overview
9.4.2 Medications: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Insect Stings
9.5.1 Overview
9.5.2 Insect Stings: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Anaphylaxis Treatment Market Analysis and Forecasts to 2028– By Distribution Channel
10.1 Overview
10.2 Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)
10.3 Retail Sales
10.3.1 Overview
10.3.2 Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
10.4 Hospital Pharmacies
10.4.1 Overview
10.4.2 Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
10.5 Others
10.5.1 Overview
10.5.2 Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)
11. Anaphylaxis Treatment Market Revenue and Forecasts to 2028 – Geographical Analysis
11.1 Asia Pacific: Anaphylaxis Treatment Market
11.1.1 Overview
11.1.2 Asia Pacific: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
11.1.2.1 Japan: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.1 Japan: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.2 Japan: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.2.1.3 Japan: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.1.4 Japan: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.1.5 Japan: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.2.1.6 Japan: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.1.2.2 China: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.1 China: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.2 China: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.2.2.3 China: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.2.4 China: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.2.5 China: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.2.2.6 China: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.1.2.3 India: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.1 India: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.2 India: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.2.3.3 India: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.3.4 India: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.3.5 India: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.2.3.6 India: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.1.2.4 South Korea: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.4.1 South Korea: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.4.2 South Korea: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.2.4.3 South Korea: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.4.4 South Korea: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.4.5 South Korea: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.2.4.6 South Korea: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.1.2.5 Australia: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.5.1 Australia: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.5.2 Australia: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.2.5.3 Australia: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.5.4 Australia: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.5.5 Australia: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.2.5.6 Australia: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
11.1.2.6 Rest of Asia Pacific: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.6.1 Rest of Asia Pacific: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.6.2 Rest of Asia Pacific: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)
11.1.2.6.3 Rest of Asia Pacific: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.6.4 Rest of Asia Pacific: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.6.5 Rest of Asia Pacific: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)
11.1.2.6.6 Rest of Asia Pacific: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Asia Pacific Anaphylaxis Treatment Market
12.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. COMPANY PROFILES
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 ALK-Abelló A/S
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Amneal Pharmaceuticals, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline plc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Merck & Co., Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 MYLAN N.V.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Pfizer Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 TEVA PHARMACEUTICAL INDUSTRIES LTD
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Japan: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 2. Japan: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 3. Japan: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 4. Japan: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 6. China: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 7. China: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 8. China: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 9. China: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 10. China: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 11. India: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 12. India: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 13. India: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 14. India: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 15. India: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 16. South Korea: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 17. South Korea: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 18. South Korea: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 19. South Korea: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 21. Australia: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 22. Australia: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 23. Australia: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 24. Australia: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 25. Australia: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 26. Rest of Asia Pacific: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)
Table 27. Rest of Asia Pacific: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 28. Rest of Asia Pacific: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 29. Rest of Asia Pacific: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)
Table 30. Rest of Asia Pacific: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 31. Organic Developments Done by Companies
Table 32. Inorganic Developments Done by Companies
Table 33. Glossary of Terms, Anaphylaxis Treatment Market
LIST OF FIGURES
Figure 1. Anaphylaxis Treatment Market Segmentation
Figure 2. Asia Pacific Anaphylaxis Treatment Market Overview
Figure 3. Epinephrine Segment Held Largest Share of Medication Type in Anaphylaxis Treatment Market
Figure 4. Japan is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Anaphylaxis Treatment Market - Asia Pacific PEST Analysis
Figure 6. Anaphylaxis Treatment Market Impact Analysis of Driver and Restraints
Figure 7. Asia Pacific Anaphylaxis Treatment Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)
Figure 9. Epinephrine: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Antihistamines: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Steroids: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Beta-Agonist: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Anaphylaxis Treatment Market Revenue Share, Route of Administration (2020 and 2028)
Figure 15. Oral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Parenteral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028 (%)
Figure 19. Food Allergy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Medications: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Insect Stings: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)
Figure 24. Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 25. Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 26. Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)
Figure 27. Asia Pacific: Anaphylaxis Treatment Market, by Key Country – Revenue (2020) (USD Million)
Figure 28. Asia Pacific: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
Figure 29. Japan: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. China: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. India: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. South Korea: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Australia: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Rest of Asia Pacific: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 36. Growth Strategies Done by the Companies in the Market, (%)
- Amneal Pharmaceuticals Inc.
- Mylan N.V.
- Abbott
- Pfizer Inc.
- Glaxosmithkline Plc.,
- Merck And Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- ALK-ABELLó
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific anaphylaxis treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific anaphylaxis treatment market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the anaphylaxis treatment market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution